This page is designed to provide a clear, accessible overview of CAR T-cell therapy—what it is, how it works, the current state of the market, and how Powerhouse Therapeutics is advancing this technology for the next generation of cancer treatment. This information is intended for prospective investors and partners who may not have a background in cell therapy.

There are follow on readings and academic papers attached to a database at the bottom of this page if additional information is desired.

What Are CAR T-Cells?

CAR T-cells are a type of immunotherapy that uses a patient's own immune cells to fight cancer. The process involves collecting T-cells (a kind of white blood cell) from the patient, genetically engineering them in the lab to express a synthetic receptor called a Chimeric Antigen Receptor (CAR), and then returning these engineered cells to the patient. The CAR enables the T-cells to recognize and attack cancer cells with high precision.

<aside> 💡

In simple terms: CAR T-cell therapy turns a patient's own immune cells into targeted cancer hunters, capable of seeking out and destroying cancer cells that would otherwise evade the immune system. This approach has shown remarkable results, especially in certain blood cancers, and is now being adapted to tackle solid tumors—the most common and deadly forms of cancer.

</aside>

How Does CAR T-Cell Therapy Work?

The Four-Step Process

  1. Collection: T-cells are collected from the patient's blood.
  2. Engineering: In the lab, these T-cells are modified to add a CAR, which is designed to recognize a specific marker (antigen) found on cancer cells.
  3. Expansion: The engineered CAR T-cells are multiplied to create millions of these cancer-targeting cells.
  4. Infusion: The CAR T-cells are infused back into the patient, where they seek out and destroy cancer cells.

This therapy is personalized, meaning each treatment is tailored to the individual patient, which helps reduce the risk of immune rejection and increases effectiveness.

Chimeric Antigen Receptor (CAR) T Cell Therapy_ Vein-to-Vein Process (5).png

Understanding Different Types of Cell-Based Immunotherapy

CAR T-cell therapy is one of several approaches that harness the power of the immune system to fight cancer. To understand what makes CAR T unique, it's helpful to know how it compares to other cell-based therapies. Here's a brief overview of four major approaches:

TILs Therapy (Tumor-Infiltrating Lymphocytes)

<aside> 🔍

Think of this as: Recruiting soldiers already at the battlefield.

</aside>